Nicotinamide Mononucleotide (NMN) Industry Research Report 2023

Nicotinamide Mononucleotide (NMN) Industry Research Report 2023


The Nicotinamide Mononucleotide (NMN) market covers Content <98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.

Highlights

The global Nicotinamide Mononucleotide (NMN) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2024 and 2029.
The main global Nicotinamide Mononucleotide (NMN) players include GeneHarbor, Herbalmax, Shinkowa Pharmaceutical, EffePharm, etc. The top four Nicotinamide Mononucleotide (NMN) players account for approximately 83% of the total market. Asia-Pacific is the largest consumer market for Nicotinamide Mononucleotide (NMN), accounting for about 76%, followed by Europe and Americas. In terms of type, Content ≥98% is the largest segment, with a share over 99%. And in terms of application, the largest application is Health Care Products, followed by Cosmetics.
The downstream applications of nicotinamide mononucleotide include health care products and cosmetics. Health products are the largest application market. In 2019, health products accounted for 98% of the total downstream consumption of nicotinamide mononucleotide in global.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Mononucleotide (NMN).
The Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Product Type Insights

Global markets are presented by Nicotinamide Mononucleotide (NMN) type, along with growth forecasts through 2029. Estimates on production and value are based on the price in the supply chain at which the Nicotinamide Mononucleotide (NMN) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Nicotinamide Mononucleotide (NMN) segment by Type

Content below 98%
Content above 98%

Application Insights

This report has provided the market size (production and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Nicotinamide Mononucleotide (NMN) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Nicotinamide Mononucleotide (NMN) market.
Nicotinamide Mononucleotide (NMN) segment by Application

Health Care Products
Cosmetics
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast value for 2029.
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Nicotinamide Mononucleotide (NMN) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Nicotinamide Mononucleotide (NMN) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Mononucleotide (NMN).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Nicotinamide Mononucleotide (NMN) by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Content below 98%
1.2.3 Content above 98%
2.3 Nicotinamide Mononucleotide (NMN) by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.3.2 Health Care Products
2.3.3 Cosmetics
2.3.4 Others
2.4 Global Market Growth Prospects
2.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
2.4.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2018-2029)
2.4.3 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2018-2029)
2.4.4 Global Nicotinamide Mononucleotide (NMN) Market Average Price (2018-2029)
3 Market Competitive Landscape by Manufacturers
3.1 Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2018-2023)
3.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2018-2023)
3.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2018-2023)
3.4 Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
3.5 Global Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
3.7 Global Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
3.8 Global Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 GeneHarbor
4.1.1 GeneHarbor Nicotinamide Mononucleotide (NMN) Company Information
4.1.2 GeneHarbor Nicotinamide Mononucleotide (NMN) Business Overview
4.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.1.4 GeneHarbor Product Portfolio
4.1.5 GeneHarbor Recent Developments
4.2 Herbalmax
4.2.1 Herbalmax Nicotinamide Mononucleotide (NMN) Company Information
4.2.2 Herbalmax Nicotinamide Mononucleotide (NMN) Business Overview
4.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.2.4 Herbalmax Product Portfolio
4.2.5 Herbalmax Recent Developments
4.3 Genex Formulas
4.3.1 Genex Formulas Nicotinamide Mononucleotide (NMN) Company Information
4.3.2 Genex Formulas Nicotinamide Mononucleotide (NMN) Business Overview
4.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.3.4 Genex Formulas Product Portfolio
4.3.5 Genex Formulas Recent Developments
4.4 Shinkowa Pharmaceutical
4.4.1 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Company Information
4.4.2 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Business Overview
4.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.4.4 Shinkowa Pharmaceutical Product Portfolio
4.4.5 Shinkowa Pharmaceutical Recent Developments
4.5 Maac10 Formulas
4.5.1 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Company Information
4.5.2 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Business Overview
4.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.5.4 Maac10 Formulas Product Portfolio
4.5.5 Maac10 Formulas Recent Developments
4.6 EffePharm
4.6.1 EffePharm Nicotinamide Mononucleotide (NMN) Company Information
4.6.2 EffePharm Nicotinamide Mononucleotide (NMN) Business Overview
4.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.6.4 EffePharm Product Portfolio
4.6.5 EffePharm Recent Developments
4.7 Bontac
4.7.1 Bontac Nicotinamide Mononucleotide (NMN) Company Information
4.7.2 Bontac Nicotinamide Mononucleotide (NMN) Business Overview
4.7.3 Bontac Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.7.4 Bontac Product Portfolio
4.7.5 Bontac Recent Developments
4.8 CELFULL
4.8.1 CELFULL Nicotinamide Mononucleotide (NMN) Company Information
4.8.2 CELFULL Nicotinamide Mononucleotide (NMN) Business Overview
4.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.8.4 CELFULL Product Portfolio
4.8.5 CELFULL Recent Developments
4.9 Kingdomway
4.9.1 Kingdomway Nicotinamide Mononucleotide (NMN) Company Information
4.9.2 Kingdomway Nicotinamide Mononucleotide (NMN) Business Overview
4.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.9.4 Kingdomway Product Portfolio
4.9.5 Kingdomway Recent Developments
5 Global Nicotinamide Mononucleotide (NMN) Production by Region
5.1 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.2 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2029
5.2.1 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2023
5.2.2 Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029)
5.3 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.4 Global Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2029
5.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2023
5.4.2 Global Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029)
5.5 Global Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2018-2023)
5.6 Global Nicotinamide Mononucleotide (NMN) Production and Value, YOY Growth
5.6.1 North America Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.2 China Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.3 Japan Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
6 Global Nicotinamide Mononucleotide (NMN) Consumption by Region
6.1 Global Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
6.2 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2029)
6.2.1 Global Nicotinamide Mononucleotide (NMN) Consumption by Region: 2018-2029
6.2.2 Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029)
6.3 North America
6.3.1 North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.4.2 Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.5.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.6.2 Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 Segment by Type
7.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2018-2029)
7.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2018-2029) & (Kg)
7.1.2 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2018-2029)
7.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2018-2029)
7.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2018-2029) & (US$ Million)
7.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2018-2029)
7.3 Global Nicotinamide Mononucleotide (NMN) Price by Type (2018-2029)
8 Segment by Application
8.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029)
8.1.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.1.2 Global Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029)
8.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029) & (US$ Million)
8.2.2 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
8.3 Global Nicotinamide Mononucleotide (NMN) Price by Application (2018-2029)
9 Value Chain and Sales Channels Analysis of the Market
9.1 Nicotinamide Mononucleotide (NMN) Value Chain Analysis
9.1.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Nicotinamide Mononucleotide (NMN) Production Mode & Process
9.2 Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Nicotinamide Mononucleotide (NMN) Distributors
9.2.3 Nicotinamide Mononucleotide (NMN) Customers
10 Global Nicotinamide Mononucleotide (NMN) Analyzing Market Dynamics
10.1 Nicotinamide Mononucleotide (NMN) Industry Trends
10.2 Nicotinamide Mononucleotide (NMN) Industry Drivers
10.3 Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
10.4 Nicotinamide Mononucleotide (NMN) Industry Restraints
11 Report Conclusion
12 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Kg) & (2018-2023)
Table 6. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers
Table 7. Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million) & (2018-2023)
Table 8. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2018-2023)
Table 9. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 10. Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 11. Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. GeneHarbor Nicotinamide Mononucleotide (NMN) Company Information
Table 16. GeneHarbor Business Overview
Table 17. GeneHarbor Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 18. GeneHarbor Product Portfolio
Table 19. GeneHarbor Recent Developments
Table 20. Herbalmax Nicotinamide Mononucleotide (NMN) Company Information
Table 21. Herbalmax Business Overview
Table 22. Herbalmax Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 23. Herbalmax Product Portfolio
Table 24. Herbalmax Recent Developments
Table 25. Genex Formulas Nicotinamide Mononucleotide (NMN) Company Information
Table 26. Genex Formulas Business Overview
Table 27. Genex Formulas Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 28. Genex Formulas Product Portfolio
Table 29. Genex Formulas Recent Developments
Table 30. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Company Information
Table 31. Shinkowa Pharmaceutical Business Overview
Table 32. Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 33. Shinkowa Pharmaceutical Product Portfolio
Table 34. Shinkowa Pharmaceutical Recent Developments
Table 35. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Company Information
Table 36. Maac10 Formulas Business Overview
Table 37. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 38. Maac10 Formulas Product Portfolio
Table 39. Maac10 Formulas Recent Developments
Table 40. EffePharm Nicotinamide Mononucleotide (NMN) Company Information
Table 41. EffePharm Business Overview
Table 42. EffePharm Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 43. EffePharm Product Portfolio
Table 44. EffePharm Recent Developments
Table 45. Bontac Nicotinamide Mononucleotide (NMN) Company Information
Table 46. Bontac Business Overview
Table 47. Bontac Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 48. Bontac Product Portfolio
Table 49. Bontac Recent Developments
Table 50. CELFULL Nicotinamide Mononucleotide (NMN) Company Information
Table 51. CELFULL Business Overview
Table 52. CELFULL Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 53. CELFULL Product Portfolio
Table 54. CELFULL Recent Developments
Table 55. Kingdomway Nicotinamide Mononucleotide (NMN) Company Information
Table 56. Kingdomway Business Overview
Table 57. Kingdomway Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 58. Kingdomway Product Portfolio
Table 59. Kingdomway Recent Developments
Table 60. Global Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 61. Global Nicotinamide Mononucleotide (NMN) Production by Region (2018-2023) & (Kg)
Table 62. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2018-2023)
Table 63. Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029) & (Kg)
Table 64. Global Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2024-2029)
Table 65. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2018-2023) & (US$ Million)
Table 67. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2018-2023)
Table 68. Global Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029) & (US$ Million)
Table 69. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2024-2029)
Table 70. Global Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2018-2023)
Table 71. Global Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 72. Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2023) & (Kg)
Table 73. Global Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2018-2023)
Table 74. Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029) & (Kg)
Table 75. Global Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2024-2029)
Table 76. North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 77. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 78. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 79. Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 80. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 81. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 82. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 83. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 84. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 85. Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 86. Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 87. Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 88. Global Nicotinamide Mononucleotide (NMN) Production by Type (2018-2023) & (Kg)
Table 89. Global Nicotinamide Mononucleotide (NMN) Production by Type (2024-2029) & (Kg)
Table 90. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2018-2023)
Table 91. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2024-2029)
Table 92. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2018-2023) & (US$ Million)
Table 93. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2024-2029) & (US$ Million)
Table 94. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2018-2023)
Table 95. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2024-2029)
Table 96. Global Nicotinamide Mononucleotide (NMN) Price by Type (2018-2023) & (US$/Kg)
Table 97. Global Nicotinamide Mononucleotide (NMN) Price by Type (2024-2029) & (US$/Kg)
Table 98. Global Nicotinamide Mononucleotide (NMN) Production by Application (2018-2023) & (Kg)
Table 99. Global Nicotinamide Mononucleotide (NMN) Production by Application (2024-2029) & (Kg)
Table 100. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2023)
Table 101. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2024-2029)
Table 102. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2023) & (US$ Million)
Table 103. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2024-2029) & (US$ Million)
Table 104. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2023)
Table 105. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2024-2029)
Table 106. Global Nicotinamide Mononucleotide (NMN) Price by Application (2018-2023) & (US$/Kg)
Table 107. Global Nicotinamide Mononucleotide (NMN) Price by Application (2024-2029) & (US$/Kg)
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. Nicotinamide Mononucleotide (NMN) Distributors List
Table 111. Nicotinamide Mononucleotide (NMN) Customers List
Table 112. Nicotinamide Mononucleotide (NMN) Industry Trends
Table 113. Nicotinamide Mononucleotide (NMN) Industry Drivers
Table 114. Nicotinamide Mononucleotide (NMN) Industry Restraints
Table 115. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Nicotinamide Mononucleotide (NMN)Product Picture
Figure 5. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Figure 6. Content below 98% Product Picture
Figure 7. Content above 98% Product Picture
Figure 8. Health Care Products Product Picture
Figure 9. Cosmetics Product Picture
Figure 10. Others Product Picture
Figure 11. Global Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Nicotinamide Mononucleotide (NMN) Production Value (2018-2029) & (US$ Million)
Figure 13. Global Nicotinamide Mononucleotide (NMN) Production Capacity (2018-2029) & (Kg)
Figure 14. Global Nicotinamide Mononucleotide (NMN) Production (2018-2029) & (Kg)
Figure 15. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2018-2029)
Figure 16. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
Figure 17. Global Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
Figure 18. Global Top 5 and 10 Nicotinamide Mononucleotide (NMN) Players Market Share by Production Valu in 2022
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 20. Global Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 21. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 22. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 23. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 24. North America Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 25. China Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 26. Japan Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 27. Global Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 28. Global Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 29. North America Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 30. North America Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 31. United States Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 32. Canada Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 33. Europe Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 34. Europe Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 35. Germany Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 36. France Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 37. U.K. Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 38. Italy Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 39. Netherlands Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 40. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 41. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 42. China Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 43. Japan Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 44. South Korea Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 45. China Taiwan Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 46. Southeast Asia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 47. India Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 48. Australia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 49. Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 50. Latin America, Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 51. Mexico Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 52. Brazil Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 53. Turkey Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 54. GCC Countries Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 55. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2018-2029)
Figure 56. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2018-2029)
Figure 57. Global Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Type (2018-2029)
Figure 58. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2029)
Figure 59. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
Figure 60. Global Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2018-2029)
Figure 61. Nicotinamide Mononucleotide (NMN) Value Chain
Figure 62. Nicotinamide Mononucleotide (NMN) Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings